Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.32 USD
0.67%
Market Closed
Updated:
May 10, 2024
Prestige Consumer Healthcare Inc
Net Issuance of Debt
|
Prestige Consumer Healthcare Inc
Net Issuance of Debt Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Net Issuance of Debt
-$232.8m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Debt
-$11.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Debt
$17.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Debt
$35.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
52%
|
CAGR 10-Years
68%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Debt
$3.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Debt
$7.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Prestige Consumer Healthcare Inc's Net Issuance of Debt?
Net Issuance of Debt
-232.8m
USD
-232.8m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Net Issuance of Debt amounts to -232.8m USD.
What is Prestige Consumer Healthcare Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-1%
-1%
Over the last year, the Net Issuance of Debt growth was -107%. The average annual Net Issuance of Debt growth rates for Prestige Consumer Healthcare Inc have been -14% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
